Susan E. Siegel - 26 May 2022 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Susan E. Siegel
Issuer symbol
N/A
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 20:58:44 UTC
Previous filing
27 May 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +4,155 +331% $0.000000 5,410 26 May 2022 Direct F1, F2
holding NVRO Common Stock 628 26 May 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer.
F2 Includes 5,410 RSUs.
F3 Shares held by Bob Reed and Susan Siegel as trustees of the Reed-Siegal Revocable Trust.